Ascendis Pharma A/S EV/EBIT
Quel est le EV/EBIT de Ascendis Pharma A/S?
Le EV/EBIT de Ascendis Pharma A/S est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Ascendis Pharma A/S
Que fait Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Entreprises avec ev/ebit similaire à Ascendis Pharma A/S
- Surface Transforms Plc a EV/EBIT de N/A
- Boqii Ltd a EV/EBIT de N/A
- Sunrun a EV/EBIT de N/A
- Mind Medicine (MindMed) a EV/EBIT de N/A
- Coveo Solutions a EV/EBIT de N/A
- Innovative Designs a EV/EBIT de N/A
- Ascendis Pharma A/S a EV/EBIT de N/A
- Biomerica a EV/EBIT de N/A
- Crescent NV a EV/EBIT de N/A
- Ivrnet a EV/EBIT de N/A
- Orion Office REIT a EV/EBIT de N/A
- Ansal Properties & Infrastructure a EV/EBIT de N/A
- Nanophase Technologies a EV/EBIT de N/A